Given all these unknowns, it may be best for Congress to pump the brakes on expanding GLP-1s in Medicare before we have a better understanding of their full value and a way to pay for it.
For adult patients, instruct patients who miss a dose of TRESIBA to inject their daily dose during waking hours upon discovering the missed dose
AUCKLAND, New Zealand--(BUSINESS WIRE)--Jul 23, 2026-- Calocurb, the New Zealand-based company bringing the world the first 100% natural GLP-1 activator, announces today the publication of a new clinical study in US medical journal, Obesity Pillars, demonstrating Calocurbs effectiveness in weight loss and muscle preservation
Improvements in access will take time, and require generation of compelling data (e.g., pharmacoeconomics, impact on comorbidities) and savvy commercial strategy
For anyone interested in exploring their options or seeking personalized advice on testing and treatment, we encourage you to sign up for a consultation with a Healthon clinician
Treating only the surface without supporting the skin's healing environment is why PIH is so stubborn for so many people
